Literature DB >> 20056272

A hydrogel-based stem cell delivery system to treat retinal degenerative diseases.

Brian G Ballios1, Michael J Cooke, Derek van der Kooy, Molly S Shoichet.   

Abstract

Regenerative strategies for retinal degenerative diseases are limited by poor cellular survival, distribution and integration after transplantation to the sub-retinal space. To overcome this limitations a stem cell delivery system was developed, taking advantage of the minimally-invasive, injectable and biodegradable properties of a blend of hyaluronan and methylcellulose (HAMC). The physical and biological properties of this unique HAMC formulation were studied. HAMC supported retinal stem-progenitor cell (RSPC) survival and proliferation in vitro. The blend was a viscous solution, exhibiting properties ideal for delivery to the sub-retinal space. In vivo transplantation studies in mice were carried out to investigate both the biodegradability of HAMC in the sub-retinal space over 7 days and the potential of HAMC as a cell delivery vehicle. RSPCs delivered in HAMC were more evenly distributed in the sub-retinal space than those delivered in traditional saline solutions, suggesting that HAMC is a promising vehicle for cellular delivery to the degenerating retina overcoming previously reported barriers to tissue integration in the retina such as cellular aggregation and non-contiguous distribution. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20056272     DOI: 10.1016/j.biomaterials.2009.12.004

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  37 in total

1.  Generation and clonal isolation of retinal stem cells from human embryonic stem cells.

Authors:  Laura Clarke; Brian G Ballios; Derek van der Kooy
Journal:  Eur J Neurosci       Date:  2012-05-16       Impact factor: 3.386

Review 2.  Regenerative therapies for central nervous system diseases: a biomaterials approach.

Authors:  Roger Y Tam; Tobias Fuehrmann; Nikolaos Mitrousis; Molly S Shoichet
Journal:  Neuropsychopharmacology       Date:  2013-09-04       Impact factor: 7.853

3.  Human melanopsin-AAV2/8 transfection to retina transiently restores visual function in rd1 mice.

Authors:  Ming-Ming Liu; Jia-Man Dai; Wen-Yi Liu; Cong-Jian Zhao; Bin Lin; Zheng-Qin Yin
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

4.  Bimodal in vivo imaging provides early assessment of stem-cell-based photoreceptor engraftment.

Authors:  C R J Laver; A L Metcalfe; L Szczygiel; A Yanai; M V Sarunic; K Gregory-Evans
Journal:  Eye (Lond)       Date:  2015-03-13       Impact factor: 3.775

5.  Advanced Materials to Enhance Central Nervous System Tissue Modeling and Cell Therapy.

Authors:  Riya J Muckom; Rocío G Sampayo; Hunter J Johnson; David V Schaffer
Journal:  Adv Funct Mater       Date:  2020-08-12       Impact factor: 18.808

Review 6.  Hydrogel-based ocular drug delivery systems: Emerging fabrication strategies, applications, and bench-to-bedside manufacturing considerations.

Authors:  Remy C Cooper; Hu Yang
Journal:  J Control Release       Date:  2019-05-22       Impact factor: 9.776

7.  Synthesis and Gelation Characteristics of Photo-Crosslinkable Star Poly(ethylene oxide-co-lactide-glycolide acrylate) Macromonomers.

Authors:  Seyedsina Moeinzadeh; Saied Nouri Khorasani; Junyu Ma; Xuezhong He; Esmaiel Jabbari
Journal:  Polymer (Guildf)       Date:  2011-08-18       Impact factor: 4.430

8.  Design of Injectable Materials to Improve Stem Cell Transplantation.

Authors:  Laura M Marquardt; Sarah C Heilshorn
Journal:  Curr Stem Cell Rep       Date:  2016-07-01

9.  Scaffolds and stem cells: delivery of cell transplants for retinal degenerations.

Authors:  Karl E Kador; Jeffrey L Goldberg
Journal:  Expert Rev Ophthalmol       Date:  2012-10-01

10.  Prevention of peritoneal adhesions using polymeric rheological blends.

Authors:  Todd Hoare; Yoon Yeo; Evangelia Bellas; Joost P Bruggeman; Daniel S Kohane
Journal:  Acta Biomater       Date:  2013-12-21       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.